The multiple faces of valosin-containing protein-associated diseases: Inclusion body myopathy with Paget's disease of bone, frontotemporal dementia, and amyotrophic lateral sclerosis

Journal of Molecular Neuroscience

Volumn 45, Issue 3, 2011, Pages 522-531

  Nalbandian, Angèle ^a   Donkervoort, Sandra ^a   Dec, Eric ^a   Badadani, Mallikarjun ^a   Katheria, Veeral ^a   Rana, Prachi ^a   Nguyen, Christopher ^a   Mukherjee, Jogeshwar ^a   Caiozzo, Vincent ^a   Martin, Barbara ^b   Watts, Giles D ^c   Vesa, Jouni ^a   Smith, Charles ^b   Kimonis, Virginia E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

Amyotrophic lateral sclerosis; Autophagy; Endoplasmic reticulum associated degradation; Frontotemporal dementia; Inclusion body myopathy; NFKB; Paget's disease of bone; TAR DNA Binding Protein 43; Ubiquitin; Valosin containing protein

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; VALOSIN CONTAINING PROTEIN;

AMYOTROPHIC LATERAL SCLEROSIS; AUTOPHAGY; CONFERENCE PAPER; DISEASE ASSOCIATION; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; HUMAN; IN VITRO STUDY; INCLUSION BODY MYOPATHY; MUSCLE ATROPHY; MYOBLAST; MYOPATHY; NEUROPATHOLOGY; NONHUMAN; PAGET BONE DISEASE; PATHOGENESIS; PHENOTYPE;

ADENOSINE TRIPHOSPHATASES; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; AUTOPHAGY; CELL CYCLE PROTEINS; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; FRONTOTEMPORAL DEMENTIA; GENETIC ASSOCIATION STUDIES; HUMANS; MUTATION; MYOSITIS, INCLUSION BODY; OSTEITIS DEFORMANS;

ANIMALIA; DYSNOMIA;

EID: 80855123678     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-011-9627-y     Document Type: Conference Paper

References (90)

1. S Acharyya, et al. 2007 Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy J Clin Invest 117 889 901 17380205 10.1172/JCI30556 1:CAS:528:DC%2BD2sXktVOisbs%3D
2. BB Aggarwal 2004 Nuclear factor-kappaB: the enemy within Cancer Cell 6 203 208 15380510 10.1016/j.ccr.2004.09.003 1:CAS:528:DC%2BD2cXot1Kis78%3D
3. G Alexandru, et al. 2008 UBXD7 binds multiple ubiquitin ligases and implicates p97 in HIF1alpha turnover Cell 134 804 816 18775313 10.1016/j.cell.2008.06.048 1:CAS:528:DC%2BD1cXhtFCqs7bM
4. A Alonso, et al. 2009 Incidence and lifetime risk of motor neuron disease in the United Kingdom: a population-based study Eur J Neurol 16 745 751 19475756 10.1111/j.1468-1331.2009.02586.x 1:STN:280:DC%2BD1MznsFentQ%3D%3D
5. SE Arnold, et al. 2000 Quantitative neurohistological features of frontotemporal degeneration Neurobiol Aging 21 913 919 11124442 10.1016/S0197-4580(00)00173-1 1:CAS:528:DC%2BD3cXovFKjsr8%3D
6. M Badadani, et al. 2010 VCP associated inclusion body myopathy and Paget disease of bone knock-in mouse model exhibits tissue pathology typical of human disease PLoS One 5 1 15 10.1371/journal.pone.0013183
7. WE Balch, et al. 2008 Adapting proteostasis for disease intervention Science 319 916 919 18276881 10.1126/science.1141448 1:CAS:528: DC%2BD1cXhslOmtLw%3D
8. A Bersano, et al. 2009 Inclusion body myopathy and frontotemporal dementia caused by a novel VCP mutation Neurobiol Aging 30 752 758 17889967 10.1016/j.neurobiolaging.2007.08.009 1:CAS:528:DC%2BD1MXjsVKqt7k%3D
9. S Bhatnagar A Kumar 2010 Therapeutic targeting of signaling pathways in muscular dystrophy J Mol Med 88 155 166 19816663 10.1007/s00109-009-0550-4 1:CAS:528:DC%2BC3cXivVGqsL0%3D
10. NJ Cairns, et al. 2007 TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions Am J Pathol 171 227 240 17591968 10.2353/ajpath.2007.070182 1:CAS:528:DC%2BD2sXosVals7c%3D
11. YC Chang, et al. 2011 Pathogenic VCP/TER94 alleles are dominant actives and contribute to neurodegeneration by altering cellular ATP level in a Drosophila IBMPFD model PLoS Genet 7 e1001288 21304887 10.1371/journal.pgen. 1001288 1:CAS:528:DC%2BC3MXitV2rsLY%3D
12. F Confalonieri M Duguet 1995 A 200-amino acid ATPase module in search of a basic function Bioessays 17 639 650 7646486 10.1002/bies.950170710 1:CAS:528:DyaK2MXnsFKmsL0%3D
13. V Crippa, et al. 2010 A role of small heat shock protein B8 (HspB8) in the autophagic removal of misfolded proteins responsible for neurodegenerative diseases Autophagy 6 958 960 20699640 10.4161/auto.6.7.13042
14. V Crippa, et al. 2010 The small heat shock protein B8 (HspB8) promotes autophagic removal of misfolded proteins involved in amyotrophic lateral sclerosis (ALS) Hum Mol Genet 19 3440 3456 20570967 10.1093/hmg/ddq257 1:CAS:528:DC%2BC3cXpvVGqu7Y%3D
15. SK Custer, et al. 2010 Transgenic mice expressing mutant forms VCP/p97 recapitulate the full spectrum of IBMPFD including degeneration in muscle, brain and bone Hum Mol Genet 19 1741 1755 20147319 10.1093/hmg/ddq050 1:CAS:528:DC%2BC3cXksFKnsLc%3D
16. RM Dai, et al. 1998 Involvement of valosin-containing protein, an ATPase Co-purified with IkappaBalpha and 26 S proteasome, in ubiquitin-proteasome- mediated degradation of IkappaBalpha J Biol Chem 273 3562 3573 9452483 10.1074/jbc.273.6.3562 1:CAS:528:DyaK1cXhtVymu7s%3D
17. RM Dai CC Li 2001 Valosin-containing protein is a multi-ubiquitin chain-targeting factor required in ubiquitin-proteasome degradation Nat Cell Biol 3 740 744 11483959 10.1038/35087056 1:CAS:528:DC%2BD3MXmtFensLs%3D
18. A Daroszewska SH Ralston 2006 Mechanisms of disease: genetics of Paget's disease of bone and related disorders Nat Clin Pract Rheumatol 2 270 277 16932700 10.1038/ncprheum0172 1:CAS:528:DC%2BD28Xltlagurk%3D
19. B DeLaBarre, et al. 2006 Central pore residues mediate the p97/VCP activity required for ERAD Mol Cell 22 451 462 16713576 10.1016/j.molcel.2006. 03.036 1:CAS:528:DC%2BD28XlsFWiu70%3D
20. A Djamshidian, et al. 2009 A novel mutation in the VCP gene (G157R) in a German family with inclusion-body myopathy with Paget disease of bone and frontotemporal dementia Muscle Nerve 39 389 391 19208399 10.1002/mus.21225 1:CAS:528:DC%2BD1MXjvVajtrY%3D
21. RD Fanganiello, et al. 2011 A Brazilian family with hereditary inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia Braz J Med Biol Res 44 374 380 21412659 10.1590/S0100-879X2011007500028 1:STN:280:DC%2BC3MvisF2ntQ%3D%3D
22. Farpour F et al (2011) Radiological features of Paget disease of bone associated with VCP myopathy. PMID: 21643886
23. V Fernandez-Saiz A Buchberger 2010 Imbalances in p97 co-factor interactions in human proteinopathy EMBO Rep 11 479 485 20414249 10.1038/embor.2010.49 1:CAS:528:DC%2BC3cXltV2ksLY%3D
24. T Gidaro, et al. 2008 An Italian family with inclusion-body myopathy and frontotemporal dementia due to mutation in the VCP gene Muscle Nerve 37 111 114 17763460 10.1002/mus.20890
25. KM Graham, et al. 2010 Excessive collagen accumulation in dystrophic (mdx) respiratory musculature is independent of enhanced activation of the NF-kappaB pathway J Neurol Sci 294 43 50 20471037 10.1016/j.jns.2010.04.007 1:CAS:528:DC%2BC3cXnsVamtL0%3D
26. L Guyant-Marechal, et al. 2006 Valosin-containing protein gene mutations: clinical and neuropathologic features Neurology 67 644 651 16790606 10.1212/01.wnl.0000225184.14578.d3 1:CAS:528:DC%2BD28XnvVynsLw%3D
27. KM Haslbeck, et al. 2005 The RAGE pathway in inflammatory myopathies and limb girdle muscular dystrophy Acta Neuropathol 110 247 254 15986224 10.1007/s00401-005-1043-3 1:CAS:528:DC%2BD2MXhtVektrvK
28. D Haubenberger, et al. 2005 Inclusion body myopathy and Paget disease is linked to a novel mutation in the VCP gene Neurology 65 1304 1305 16247064 10.1212/01.wnl.0000180407.15369.92 1:STN:280:DC%2BD2MrmvFOrtg%3D%3D
29. MS Hayden S Ghosh 2004 Signaling to NF-kappaB Genes Dev 18 2195 2224 15371334 10.1101/gad.1228704 1:CAS:528:DC%2BD2cXnslCntbY%3D
30. CU Hubbers, et al. 2007 Pathological consequences of VCP mutations on human striated muscle Brain 130 381 393 16984901 10.1093/brain/awl238
31. PC Janiesch, et al. 2007 The ubiquitin-selective chaperone CDC-48/p97 links myosin assembly to human myopathy Nat Cell Biol 9 379 390 17369820 10.1038/ncb1554 1:CAS:528:DC%2BD2sXjs1yqu7g%3D
32. E Jarosch, et al. 2002 Protein dislocation from the endoplasmic reticulum-pulling out the suspect Traffic 3 530 536 12121416 10.1034/j.1600-0854.2002.30803.x 1:CAS:528:DC%2BD38XlvFerurs%3D
33. JO Johnson, et al. 2010 Exome sequencing reveals VCP mutations as a cause of familial ALS Neuron 68 857 864 21145000 10.1016/j.neuron.2010.11.036 1:CAS:528:DC%2BC3cXhsFGhu73J
34. JS Ju CC Weihl 2010 Inclusion body myopathy, Paget's disease of the bone and fronto-temporal dementia: a disorder of autophagy Hum Mol Genet 19 R38 R45 20410287 10.1093/hmg/ddq157 1:CAS:528:DC%2BC3cXmsVSrtLY%3D
35. A Kakizuka 2008 Roles of VCP in human neurodegenerative disorders Biochem Soc Trans 36 105 108 18208395 10.1042/BST0360105 1:CAS:528:DC%2BD1cXht1ajurc%3D
36. M Kaleem, et al. 2007 Identification of a novel valosin-containing protein polymorphism in late-onset Alzheimer's disease Neurodegener Dis 4 376 381 17622780 10.1159/000105158 1:CAS:528:DC%2BD2sXotVOjsb8%3D
37. EJ Kim YE Park DS Kim, et al. 2011 Inclusion body myopathy with Paget disease of bone and frontotemporal dementia linked to VCP p.Arg155Cys in a Korean family Arch Neurol 68 787 796 21320982 10.1001/archneurol.2010.376
38. VE Kimonis, et al. 2008 VCP disease associated with myopathy, Paget disease of bone and frontotemporal dementia: review of a unique disorder Biochim Biophys Acta 1782 744 748 18845250 1:CAS:528:DC%2BD1cXhsVCntb%2FK
39. VE Kimonis, et al. 2000 Clinical and molecular studies in a unique family with autosomal dominant limb-girdle muscular dystrophy and Paget disease of bone Genet Med 2 232 241 11252708 10.1097/00125817-200007000-00006 1:STN:280:DC%2BD3M3islWrtQ%3D%3D
40. VE Kimonis, et al. 2008 Clinical studies in familial VCP myopathy associated with Paget disease of bone and frontotemporal dementia Am J Med Genet A 146A 745 757 18260132 10.1002/ajmg.a.31862
41. H Kondo, et al. 1997 p47 is a cofactor for p97-mediated membrane fusion Nature 388 75 78 9214505 10.1038/40411 1:CAS:528:DyaK2sXksVSrsLw%3D
42. VI Korolchuk, et al. 2009 Autophagy inhibition compromises degradation of ubiquitin-proteasome pathway substrates Mol Cell 33 517 527 19250912 10.1016/j.molcel.2009.01.021 1:CAS:528:DC%2BD1MXltFSnu7Y%3D
43. MJ Kovach, et al. 2001 Clinical delineation and localization to chromosome 9p13.3-p12 of a unique dominant disorder in four families: hereditary inclusion body myopathy, Paget disease of bone, and frontotemporal dementia Mol Genet Metab 74 458 475 11749051 10.1006/mgme.2001.3256 1:CAS:528: DC%2BD3MXptFegurk%3D
44. S Krause, et al. 2007 Brain imaging and neuropsychology in late-onset dementia due to a novel mutation (R93C) of valosin-containing protein Clin Neuropathol. 26 232 240 17907600 1:STN:280:DC%2BD2sroslSjsA%3D%3D
45. KR Kumar, et al. 2010 Two Australian families with inclusion-body myopathy, Paget's disease of bone and frontotemporal dementia: novel clinical and genetic findings Neuromuscul Disord 20 330 334 20335036 10.1016/j.nmd.2010. 03.002
46. TJ Kwiatkowski Jr, et al. 2009 Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis Science 323 1205 1208 19251627 10.1126/science.1166066 1:CAS:528:DC%2BD1MXit1eltbw%3D
47. C Lagier-Tourenne, et al. 2010 TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration Hum Mol Genet 19 R46 R64 20400460 10.1093/hmg/ddq137 1:CAS:528:DC%2BC3cXmsVSrt7o%3D
48. PN Leigh LC Wijesekera 2010 Motor neuron disease: focusing the mind on ALS: updated practice parameters Nat Rev Neurol. 6 191 192 20379204 10.1038/nrneurol.2010.33
49. CE Leyton JR Hodges 2010 Frontotemporal dementias: recent advances and current controversies Ann Indian Acad Neurol 13 S74 S80 21369422
50. SC Ling, et al. 2010 ALS-associated mutations in TDP-43 increase its stability and promote TDP-43 complexes with FUS/TLS Proc Natl Acad Sci U S A 107 13318 13323 20624952 10.1073/pnas.1008227107 1:CAS:528:DC%2BC3cXht1GrurjJ
51. G Logroscino, et al. 2008 Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues J Neurol Neurosurg Psychiatry 79 6 11 18079297 10.1136/jnnp.2006.104828 1:STN:280:DC%2BD2sjksVGntQ%3D%3D
52. C Lomen-Hoerth, et al. 2003 Are amyotrophic lateral sclerosis patients cognitively normal? Neurology 60 1094 1097 12682312 1:STN:280: DC%2BD3s7msFSitw%3D%3D
53. V McGuire, et al. 1996 Incidence of amyotrophic lateral sclerosis in three counties in western Washington state Neurology 47 571 573 8757041 1:STN:280:DyaK28zjs1Shtw%3D%3D
54. HH Meyer, et al. 2000 A complex of mammalian ufd1 and npl4 links the AAA-ATPase, p97, to ubiquitin and nuclear transport pathways EMBO J 19 2181 2192 10811609 10.1093/emboj/19.10.2181 1:CAS:528:DC%2BD3cXjvFOmurg%3D
55. TD Miller, et al. 2009 Inclusion body myopathy with Paget disease and frontotemporal dementia (IBMPFD): clinical features including sphincter disturbance in a large pedigree J Neurol Neurosurg Psychiatry 80 583 584 19372299 10.1136/jnnp.2008.148676 1:STN:280:DC%2BD1M3ot1agsw%3D%3D
56. N Mizushima, et al. 2004 In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker Mol Biol Cell 15 1101 1111 14699058 10.1091/mbc.E03-09-0704 1:CAS:528:DC%2BD2cXitlGhu7g%3D
57. JM Muller, et al. 2007 Targeted deletion of p97 (VCP/CDC48) in mouse results in early embryonic lethality Biochem Biophys Res Commun 354 459 465 17239345 10.1016/j.bbrc.2006.12.206 1:STN:280:DC%2BD2s7lslWnsw%3D%3D
58. D Neary, et al. 1998 Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria Neurology 51 1546 1554 9855500 1:STN:280: DyaK1M%2FntFWnsA%3D%3D
59. L Pasquali, et al. 2010 The role of autophagy: what can be learned from the genetic forms of amyotrophic lateral sclerosis CNS Neurol Disord Drug Targets 9 268 278 20406184 1:CAS:528:DC%2BC3cXos1Ojsb0%3D
60. E Rabinovich, et al. 2002 AAA-ATPase p97/Cdc48p, a cytosolic chaperone required for endoplasmic reticulum-associated protein degradation Mol Cell Biol 22 626 634 11756557 10.1128/MCB.22.2.626-634.2002 1:CAS:528: DC%2BD38XhvVeqtA%3D%3D
61. C Rabouille, et al. 1998 Syntaxin 5 is a common component of the NSF- and p97-mediated reassembly pathways of Golgi cisternae from mitotic Golgi fragments in vitro Cell 92 603 610 9506515 10.1016/S0092-8674(00)81128-9 1:CAS:528:DyaK1cXhvVWqsb0%3D
62. M Rape, et al. 2001 Mobilization of processed, membrane-tethered SPT23 transcription factor by CDC48(UFD1/NPL4), a ubiquitin-selective chaperone Cell 107 667 677 11733065 10.1016/S0092-8674(01)00595-5 1:CAS:528: DC%2BD3MXptVaqtrc%3D
63. IR Reid, et al. 2005 Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease N Engl J Med 353 898 908 16135834 10.1056/NEJMoa044241 1:CAS:528:DC%2BD2MXpsFCht7g%3D
64. GP Ritson, et al. 2010 TDP-43 mediates degeneration in a novel Drosophila model of disease caused by mutations in VCP/p97 J Neurosci 30 7729 7739 20519548 10.1523/JNEUROSCI.5894-09.2010 1:CAS:528:DC%2BC3cXovVOitb8%3D
65. ED Roberson 2011 Contemporary approaches to Alzheimer's disease and frontotemporal dementia Methods Mol Biol 670 1 9 20967579 10.1007/978-1-60761- 744-0-1
66. JD Rohrer JD Warren D Reiman, et al. 2011 A novel exon 2 I27V VCP variant is associated with dissimilar clinical syndromes J Neurol 258 1494 1496 21387114 10.1007/s00415-011-5966-4
67. TE Rusten M Filimonenko LM Rodahl, et al. 2008 ESCRTing autophagic clearance of aggregating proteins Autophagy 4 233 236 1:CAS:528: DC%2BD1cXksFGru74%3D
68. R Schroder, et al. 2005 Mutant valosin-containing protein causes a novel type of frontotemporal dementia Ann Neurol 57 457 461 15732117 10.1002/ana.20407
69. CE Shaw 2010 Capturing VCP: another molecular piece in the ALS jigsaw puzzle Neuron 68 812 814 21144996 10.1016/j.neuron.2010.11.040 1:CAS:528:DC%2BC3cXhsFGhu73N
70. G Siciliano, et al. 2010 Clinical trials for neuroprotection in ALS CNS Neurol Disord Drug Targets 9 305 313 20406180 1:CAS:528:DC%2BC3cXos1Ojsbk%3D
71. E Siris, et al. 1996 Comparative study of alendronate versus etidronate for the treatment of Paget's disease of bone J Clin Endocrinol Metab 81 961 967 8772558 10.1210/jc.81.3.961 1:CAS:528:DyaK28Xhs1agsrk%3D
72. Spina et al (2008) Frontotemporal dementia associated with a valosin-containing protein mutation: report of three families. The FASEB Journal 22:58.4 (Abstract)
73. J Sreedharan, et al. 2008 TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis Science 319 1668 1672 18309045 10.1126/science.1154584 1:CAS:528:DC%2BD1cXjsVamtbo%3D
74. T Stojkovic, et al. 2009 Clinical outcome in 19 French and Spanish patients with valosin-containing protein myopathy associated with Paget's disease of bone and frontotemporal dementia Neuromuscul Disord 19 316 323 19364651 10.1016/j.nmd.2009.02.012
75. MJ Strong, et al. 2003 Cognitive impairment, frontotemporal dementia, and the motor neuron diseases Ann Neurol 54 Suppl 5 S20 S23 12833364 10.1002/ana.10574
76. BJ Traynor, et al. 1999 Incidence and prevalence of ALS in Ireland, 1995-1997: a population-based study Neurology 52 504 509 10025778 1:STN:280:DyaK1M7kvVKntw%3D%3D
77. RS Turner, et al. 1996 Clinical, neuroimaging, and pathologic features of progressive nonfluent aphasia Ann Neurol 39 166 173 8967747 10.1002/ana.410390205 1:STN:280:DyaK287psl2guw%3D%3D
78. J van der Zee, et al. 2009 Clinical heterogeneity in 3 unrelated families linked to VCP p.Arg159His Neurology 73 626 632 19704082 10.1212/WNL. 0b013e3181b389d9
79. C Vance, et al. 2009 Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6 Science 323 1208 1211 19251628 10.1126/science.1165942 1:CAS:528:DC%2BD1MXit1eltbs%3D
80. J Vesa, et al. 2009 Valosin containing protein associated inclusion body myopathy: abnormal vacuolization, autophagy and cell fusion in myoblasts Neuromuscul Disord 19 766 772 19828315 10.1016/j.nmd.2009.08.003
81. Q Wang, et al. 2004 Molecular perspectives on p97-VCP: progress in understanding its structure and diverse biological functions J Struct Biol 146 44 57 15037236 10.1016/j.jsb.2003.11.014 1:CAS:528:DC%2BD2cXisVSmtrg%3D
82. GD Watts, et al. 2003 Clinical and genetic heterogeneity in chromosome 9p associated hereditary inclusion body myopathy: exclusion of GNE and three other candidate genes Neuromuscul Disord 13 559 567 12921793 10.1016/S0960-8966(03) 00070-1
83. GD Watts, et al. 2004 Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein Nat Genet 36 377 381 15034582 10.1038/ng1332 1:CAS:528:DC%2BD2cXis1aht70%3D
84. GD Watts, et al. 2007 Novel VCP mutations in inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia Clin Genet. 72 420 426 17935506 10.1111/j.1399-0004.2007.00887.x 1:STN:280: DC%2BD2snmtlGgsw%3D%3D
85. CC Weihl, et al. 2006 Inclusion body myopathy-associated mutations in p97/VCP impair endoplasmic reticulum-associated degradation Hum Mol Genet 15 189 199 16321991 10.1093/hmg/ddi426 1:CAS:528:DC%2BD28XktF2huw%3D%3D
86. CC Weihl, et al. 2007 Transgenic expression of inclusion body myopathy associated mutant p97/VCP causes weakness and ubiquitinated protein inclusions in mice Hum Mol Genet 16 919 928 17329348 10.1093/hmg/ddm037 1:CAS:528:DC%2BD2sXmsVWnt74%3D
87. CC Weihl, et al. 2009 Valosin-containing protein disease: inclusion body myopathy with Paget's disease of the bone and fronto-temporal dementia Neuromuscul Disord 19 308 315 19380227 10.1016/j.nmd.2009.01.009
88. E Wong AM Cuervo 2010 Autophagy gone awry in neurodegenerative diseases Nat Neurosci 13 805 811 20581817 10.1038/nn.2575 1:CAS:528:DC%2BC3cXnvFSgtrw%3D
89. Y Ye, et al. 2001 The AAA ATPase Cdc48/p97 and its partners transport proteins from the ER into the cytosol Nature 414 652 656 11740563 10.1038/414652a 1:CAS:528:DC%2BD38XjtF2n
90. V Zhukareva, et al. 2001 Loss of brain tau defines novel sporadic and familial tauopathies with frontotemporal dementia Ann Neurol 49 165 175 11220736 10.1002/1531-8249(20010201)49:2<165::AID-ANA36>3.0.CO;2-3 1:CAS:528:DC%2BD3MXhsVymtbc%3D